VolitionRX Ltd Share Price OTC Bulletin Board
Equities
VNRX
US9286611077
Biotechnology & Medical Research
Sales 2024 * | 2.86M 238M | Sales 2025 * | 13.48M 1.13B | Capitalization | 55.15M 4.61B |
---|---|---|---|---|---|
Net income 2024 * | -32M -2.67B | Net income 2025 * | -22M -1.84B | EV / Sales 2024 * | 17.8 x |
Net cash position 2024 * | 4.4M 368M | Net cash position 2025 * | 25.9M 2.16B | EV / Sales 2025 * | 2.17 x |
P/E ratio 2024 * |
-1.82
x | P/E ratio 2025 * |
-2.63
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.89% |
Latest transcript on VolitionRX Ltd
Managers | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 06/11/06 |
Terig Hughes
DFI | Director of Finance/CFO | 54 | 01/21/01 |
Gaetan Michel
COO | Chief Operating Officer | 51 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 06/11/06 |
Martin Faulkes
CHM | Chairman | 80 | 06/11/06 |
Guy Innes
BRD | Director/Board Member | 67 | 06/11/06 |
1st Jan change | Capi. | |
---|---|---|
-44.08% | 7.63B | |
+8.98% | 3.61B | |
+3.94% | 2.36B | |
-24.94% | 1.86B | |
-17.38% | 1.74B | |
+4.89% | 913M | |
+21.75% | 763M | |
-11.57% | 678M | |
+4.37% | 290M |